Prospective Evaluation Study for ResistancePlus® MG
A prospective evaluation study published in the Journal of Clinical Microbiology evaluated our ResistancePlus® MG assay against 1089 symptomatic and asymptomatic male and female urine and anogenital swab samples.
- 6% positive for M. genitalium.
- 63.1% having macrolide resistance associated mutations.
This assay offers a considerable advantage in clinical settings for M. genitalium testing by making the results of macrolide resistance mutation simultaneously available, which is increasingly important with escalating macrolide resistance.
Read the full open access article at: Journal of Clinical Microbiology